Vaxzevria (previously COVID-19 Vaccine AstraZeneca) - direct healthcare professional communication (DHPC)

Chimpanzee Adenovirus encoding the SARS CoV 2 Spike glycoprotein (ChAdOx1-S)
DHPCHuman

Swedish is available via eTranslation, the European Commission's machine translation service.

Translate to Swedish | Important information about machine translation

Om

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Dokument

Direct healthcare professional communication (DHPC): Vaxzevria (previously COVID-19 Vaccine AstraZeneca): Risk of thrombocytopenia and coagulation disorders

English (EN) (166.6 KB - PDF)

Först publicerad:
Visa

Key facts

Medicine name
Vaxzevria (previously COVID-19 Vaccine AstraZeneca)
Active substance
Chimpanzee Adenovirus encoding the SARS CoV 2 Spike glycoprotein (ChAdOx1-S)
Therapeutic area (MeSH)
COVID-19 virus infection
Regulatory outcome
Variation
DHPC type
Safety signal
Human ATC codes
J07BX03
Dissemination date

Share this page